International Myeloma Foundation press release: iStopMM charts the way forward in Myeloma research and treatment. This year, iStopMM presents four oral abstracts and two posters at the American Society of Hematology (ASH) Annual Meeting held in Atlanta December 11-14. The Annual Meeting presents the newest advances in malignant and non-malignant hematology and provides a good opportunity for global networking in the community of hematologists.
Prevalence of multiple myeloma precursors revealed for the first time with iStopMM results
Researchers at iStopMM have for the first time described the prevalence of smoldering multiple myeloma and the findings indicate that it is present in 0.5%